Eupraxia Pharmaceuticals
Tracked across 2 events · 12 articles · First seen May 28, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Eupraxia Pharmaceuticals will present its Diffusphere technology and drug pipeline at the Jefferies Global Healthcare Conference, potentially increasing investor interest and visibility for its stock.
May 28, 2026 · 6 articles
Business
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, announced that its common shares commenced trading on the Nasdaq Global Select Market, the highest tier of Nasdaq, effective September 8, 2026. The shares previously traded on the…
Impact: The company upgraded its listing to the Nasdaq Global Select Market, signaling financial strength and growth, which may positively influence investor perception.
Sep 08, 2026 · 6 articles
100
Eupraxia Pharmaceuticals commenced trading NasdaqEupraxia transfers to...
40
Eupraxia Pharmaceuticals announced participationEupraxia transfers to...
ERGEN INTELLIGENCE
Track Eupraxia Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard